Tokyo Joe's Cafe / Societe Anonyme/No Pennies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nietzsche who wrote (82456)	7/8/1999 9:43:00 AM
From: reikjavic	Read Replies (4) of 119973

SAN MATEO, Calif., July 8 /PRNewswire/ -- SciClone Pharmaceuticals (Nasdaq: SCLN - news) announced today that its lead product, ZADAXIN®, significantly reduced the spread of colorectal cancer and increased survival rates when administered in combination with 5-fluorouracil (5-FU) and interleukin-2 (IL-2) in an animal model. The ZADAXIN combination therapy also stimulated significant increases in the production and activation of disease fighting helper and killer T-cells. The data were published in the current issue of the peer-reviewed journal Cancer Immunology and Immunotherapy (Vol. 48).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next